Detalles de la búsqueda
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055253
2.
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium.
Int J Cancer
; 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709956
3.
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
Br J Cancer
; 130(6): 934-940, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243011
4.
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study.
Gynecol Oncol
; 186: 191-198, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824752
5.
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
Gynecol Oncol
; 185: 202-211, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834399
6.
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.
Int J Gynecol Cancer
; 34(4): 627-630, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453176
7.
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.
Int J Gynecol Cancer
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38858103
8.
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer.
Int J Gynecol Cancer
; 34(4): 469-477, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101816
9.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627035
10.
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.
Gynecol Oncol
; 168: 68-75, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401943
11.
Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI.
Int J Gynecol Cancer
; 33(12): 1890-1897, 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597854
12.
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.
Gynecol Oncol
; 165(1): 14-22, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177277
13.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35063943
14.
TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
Cell Mol Life Sci
; 79(1): 26, 2021 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936030
15.
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
Gynecol Oncol
; 162(3): 539-545, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253389
16.
Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study.
Gynecol Oncol
; 162(3): 694-701, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253388
17.
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer.
J Surg Oncol
; 123(4): 1109-1114, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497468
18.
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial.
Int J Gynecol Cancer
; 31(4): 617-622, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318079
19.
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.
Gynecol Oncol
; 159(3): 706-711, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33019981
20.
Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
Int J Gynecol Cancer
; 30(4): 466-472, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079714